Evidence map›Paper›PMID 42650847›Full record

ReviewBiomolecules2026

Linker Histones: The Multiple Binding Modes of the Enigmatic 5th Histone.

Nicholas R Rugelis, Ashok Kumar, Jeffrey J Hayes

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicholas R RugelisDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-9026-9748
Ashok KumarDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-6482-0137
Jeffrey J HayesDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-6981-1803

Funding

Training in Wellness and Resiliency at the University of Rochester Medical Center and College of Arts, Sciences & EngineeringT32GM135134 · NIGMS · UNIVERSITY OF ROCHESTER · PI Jeffrey J Hayes, Lynne E Maquat · 2020 to 2026
$2.9M
Molecular mechanisms of the core and linker histone tail domains that drive chromatin condensationR35GM149420 · NIGMS · UNIVERSITY OF ROCHESTER · PI Jeffrey J Hayes · 2023 to 2026
$1.6M
NIGMS NIH HHS R35 GM149420NIGMS NIH HHS T32 GM135134NIH HHS 5R35GM149420
6 · The paper itself

Abstract

Chromatin structure is dynamic and regulated by many factors, including enzymes that chemically modify histones and DNA, chromatin remodeling complexes that physically manipulate nucleosomes and chromatin, and non-enzymatic proteins that bind to DNA or nucleosomes to create specialized regions in chromatin. This multifactorial regulation stems from the need for fine-tuned control, which is key in processes including DNA repair, replication, and gene expression. Linker histones are a family of proteins structurally distinct from the core histones that provide a poorly understood layer of regulation in chromatin. In this review, we introduce the basics of chromatin structure, what is known about how linker histones (H1s) bind to nucleosomes and influence chromatin, and how the individual domains within H1s contribute to these activities. We especially focus on recent studies describing canonical and alternative H1-nucleosome binding and their potential roles in chromatin.

Indexed as

ChromatinHistonesAnimalsBinding SitesChromatin Assembly and DisassemblyDNAHumansNucleosomesProtein BindingChromatinDNAHistonesNucleosomeschromatinchromatosomelinker histones (H1s)nucleosomenucleosome core particleoff-dyad bindingon-dyad binding

Identifiers

PMID42650847
PMCPMC13510831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.